Rxsight’s Light Adjustable Lens Got FDA Approval By: RxSight, Inc. News ALISO VIEJO, Calif., RxSight, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the RxSight™ Light Adjustable Lens and the Light Delivery Device (LDD) for patients with pre-existing astigmatism of ≥ 0.75 diopters undergoing cataract surgery. This [..]
FDA Approved ViiV’s Juluca® For HIV By: ViiV Healthcare News ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a complete regimen for the maintenance treatment of HIV-1 [..]
Making Fuel From Emissions By: David L. Chandler | MIT News Office MIT researchers have developed a new system that could potentially be used for converting power plant emissions of carbon dioxide into useful fuels for cars, trucks, and planes, as well as into chemical feedstocks for a wide variety [..]
New Direction for Autoimmune Drug Design Inspired by Viral Protein By: Susan Gammon | SBP Beaker Blog In the U.S. alone, 24 million people, or eight percent of the population, have autoimmune diseases such as rheumatoid arthritis, lupus, multiple sclerosis, and psoriasis. Current treatments, including the new wave of biologic [..]
FDA Approved Pfizer’s Sutent® For Renal Cell Carcinoma By: Pfizer News Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma [..]
Collision Conference NEW ORLEANS, April 30 – May 3, 2018 From the organizers of Web Summit, Collision is regarded as one of the best conferences in the world for tech entrepreneurs. Many of my peers rave about every aspect of this conference: From [..]
FDA Approved Genentech’s Hemlibra for Hemophilia A By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children [..]
Ultragenyx’s MEPSEVII™ Got FDA Approval NOVATO, Calif., (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced that the U.S. Food and Drug Administration (FDA) has approved MEPSEVII™ (vestronidase alfa), the first medicine approved for the treatment of [..]
Manta Ray Robot By NUS Scientists Which Can Swims Faster and Operates up to 10 Hours By: NUS News Researchers from the National University of Singapore (NUS) have created MantaDroid, an aquatic robot that emulates the swimming locomotion of manta rays. The robotic manta ray, which swims at the speed of twice [..]
Now You Can Get Your Blood Test Results In Minutes, On-site, With New Sysmex XW-100 : F.D.A. Approved Sysmex America announced that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each [..]
Novel Way to Make Nanoscale Emulsions By: David L. Chandler | MIT News Office The reluctance of oil and water to mix together and stay that way is so well-known that it has become a cliché for describing any two things that do not go together well. Now, a new [..]
Flexible and Stretchable Photonic Devices Developed by MIT Researchers By: David L. Chandler | MIT News Office Researchers at MIT and several other institutions have developed a method for making photonic devices — similar to electronic devices but based on light rather than electricity — that can bend and stretch [..]
Copyright © 2024 | WordPress Theme by MH Themes